Sign in →

Test ID BLOD1606 Chromosome Analysis, Hematologic Disorders, Blood

Useful For

Assisting in the classification and follow-up of certain malignant hematological disorders when bone marrow is not available

 

This test is not useful for congenital disorders.

Specimen Type

Whole blood


Ordering Guidance


This test is not appropriate for detecting constitutional/congenital chromosome abnormalities. If this test is ordered with a reason for testing indicating a concern for a constitutional/congenital chromosome abnormality, the test will be canceled and CHRCB / Chromosome Analysis, Congenital Disorders, Blood will be added and performed as the appropriate test.

 

If this test is ordered and the laboratory is informed that the patient is on a Children's Oncology Group (COG) protocol, this test will be canceled and automatically reordered by the laboratory as COGBL / Chromosome Analysis, Hematologic Disorders, Children's Oncology Group Enrollment Testing, Blood.

 

Consultation with personnel from the Cytogenetics Laboratory is recommended when considering blood studies for hematologic disorders. Call 800-533-1710 and ask for the Cytogenetics Genetic Counselor on call.



Shipping Instructions


Advise Express Mail or equivalent if not on courier service.



Necessary Information


1. A reason for testing should be submitted with each specimen. The laboratory will not reject testing if this information is not provided, but appropriate testing and interpretation may be compromised or delayed.

2. A pathology and/or flow cytometry report may be requested by the laboratory to optimize testing and aid in interpretation of results.



Specimen Required


Container/Tube:

Preferred: Yellow top (ACD)

Acceptable: Green top (sodium heparin) or lavender top (EDTA)

Specimen Volume: 6 mL

Collection Instructions:

1. Invert several times to mix blood.

2. Send whole blood specimen in original tube. Do not aliquot.


Specimen Minimum Volume

3 mL

Reject Due To

All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Specimen Stability Information

Specimen Type Temperature Time Special Container
Whole blood Ambient (preferred)
  Refrigerated 

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
_ML20 Metaphases, 1-19 No, (Bill Only) No
_M25 Metaphases, 20-25 No, (Bill Only) No
_MG25 Metaphases, >25 No, (Bill Only) No
_STAC Ag-Nor/CBL Stain No, (Bill Only) No

Day(s) Performed

Monday through Friday

Report Available

9 to 11 days

Method Name

Cell Culture without Mitogens followed by Chromosome Analysis

Testing Algorithm

This test includes a charge for cell culture of fresh specimens and professional interpretation of results. Analysis charges will be incurred for total work performed, and generally include 2 banded karyograms and the analysis of 20 metaphase cells. If no metaphase cells are available for analysis, no analysis charges will be incurred. If additional analysis work is required, additional charges may be incurred.

 

In addition to the cell culture, a CpG stimulated culture will be added, and 10 additional cells will be analyzed for any specimen received from a patient 30 years of age or older with a reason for testing of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, lymphocytosis, Waldenstrom macroglobulinemia, or any CLL fluorescence in situ hybridization test previously ordered or is ordered concurrently.

Forms

If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

88237, 88291-Tissue culture for neoplastic disorders; bone marrow, blood, Interpretation and report

88264 w/ modifier 52-Chromosome analysis with less than 20 cells (if appropriate)

88264-Chromosome analysis with 20 to 25 cells (if appropriate)

88264,88285-Chromosome analysis with greater than 25 cells (if appropriate)

88283-Additional specialized banding technique (if appropriate) 

Secondary ID

35308

Reporting Name

Chromosomes, Hematologic, Blood

Reference Values

An interpretative report will be provided.

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.